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Uranium has radioactive and chemotoxic properties. Evidence 
of cancer risk due to uranium as a radioactive element (as alpha-
transmitter and from its decay products such as radon and radium 
of higher radioactivity) has been established.[1,2] According to the 
International Agency for Research on Cancer (IARC)’s Monograph 
programme on the evaluation of carcinogenic risks to humans, 
there is limited evidence for the carcinogenicity of mixtures of 
uranium (U) isotopes in humans.[1] There is sufficient evidence 
in experimental animals for the carcinogenicity of 233U, 234U, 
235U and 238U (of which only the latter three isotopes occur 
naturally and are found in varying ratios in natural, enriched 
and depleted uranium).[1] An association between environmental 
uranium exposure and risk of haematological malignancies has 
been hypothesised, but the evidence is inconclusive.[2-4] Started in 
the mid-1880s, goldmining and milling over the past 130 years 
in the West Rand and Far West Rand basins of South Africa (SA) 
resulted in containment of an estimated >600 000 tons of uranium 
in deposited mining waste.[5] Locally high levels of environmental 
contamination from uranium and its decay products in water, soil, 
sediment and dust have been reported.[6] Owing to frequently short 
distances between mine tailings and residential areas, populations 
living around the goldmine tailings of the West Rand and Far 
West Rand goldfields may be exposed to uranium and uranium 
decay products from the tailings through multiple pathways. 
These include ingestion of contaminated water, consumption of 
possibly contaminated local products (e.g. vegetables, milk, meat) 
and inhalation of dust. In addition, direct consumption of the 
contaminated soil and tailings material (geophagia) is a suspected 
pathway. Geophagia is intentional habitual soil ingestion, common 
in sub-Saharan Africa including SA and particularly prevalent 
among pregnant women, but small children also ingest soil via 
unintentional uptake by hand-to-mouth contact. Geophagia is 
practised for treatment of gastrointestinal symptoms and as a 
morning-sickness remedy, and is related to mineral (e.g. iron) 
deficiency as well as psychological and sociocultural factors.[7] Risks 
associated with ingestion of contaminated soil including exposure 
to toxic chemicals have been hypothesised.[8,9]
The scenario described above merits research for two reasons, 
outlined during an expert workshop held by the IARC in 
Johannesburg on 13 - 14 March 2013.[9] From a public health 
perspec tive, if environmental exposure to uranium does lead to 
increased human exposure, large populations may be affected, 
and resulting health risks need to be mitigated. From a scientific 
perspective, this may be a unique setting to address the still 
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Background. South Africa (SA)’s high levels of environmental contamination of mine tailings from uranium and its decay products, 
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Objectives. We reviewed information on cases from the central hospital offering cancer diagnostics and treatment in a major mining area 
of SA to describe their basic clinical and demographic characteristics, as part of assessing whether a cancer epidemiological study in this 
area would be feasible.
Methods. Basic clinical, demographic and residential information on patients with haematological malignancy diagnosed between 2004 and 
2013 was collected retrospectively from the patient files at Chris Hani Baragwanath Academic Hospital in Soweto, Johannesburg.
Results. In total, 1 880 patients aged 18 - 94 years were identified. Referral from distant provinces was not uncommon, but >80% lived within 
50 km of the hospital. Non-Hodgkin’s lymphoma accounted for 44% of the haematological malignancies, followed by leukaemia with 26%. 
HIV status was known for 93% of the patients, of whom 47% were HIV-positive.
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patterns to the hospital, and with HIV and other infections probable important confounders. Our study therefore shows that active case 
recruitment is required for accurate assessment of residential information. However, some findings on spatial distributions in the study 
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and haematological malignancies in residents. Disproportionately high incidence rates of haematological malignancies observed in specific 
districts would be relevant for further investigation.
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inconclusive question of whether there is a detectable association 
between environmental uranium exposure and risk of cancer, 
including haematological malignancies.
In SA, ~2 000 - 3 000 cases of haematological malignancy were 
reported to the National Cancer Registry (NCR) each year between 
2004 and 2011.[10] The NCR is a pathology-based cancer registry 
and its completeness of coverage of haematological malignancies, 
especially in less affluent areas, is not known. However, haematological 
malignancies accounted for 5.1% of total cancer cases during this 
period. More than half (50.9%) were non-Hodgkin’s lymphomas 
(NHLs), followed by leukaemia (21.8%). In 2011, age-standardised 
rates per 100  000 population for all haematological malignancies 
combined were 9.25 for males and 6.19 for females. Only 37% of 
reported cases in 2011 were in black Africans, who account for 80% 
of the total population of SA.
Objectives
Chris Hani Baragwanath Academic Hospital (CHBAH) is a tertiary 
hospital located in Soweto, Johannesburg. The largest public hospital 
on the entire African continent, it has a patient catchment area 
covering the whole of Soweto and surrounding areas up to 30 km 
away and receives patients from referral hospitals located up to 
150 km away.
To date, there have been no epidemiological studies investigating 
the risk of cancer in the exposed populations living around the 
mine tailings. After the workshop mentioned above,[9] several pilot 
activities commenced in the framework of a feasibility study, with 
some aiming to quantify human exposure and how best to measure it, 
and one aiming to obtain an overview of patients with haematological 
malignancies in the area reported on here. The main objective of the 
case series analysis of haematological cancer patients from CHBAH 
was to describe the basic clinical and demographic characteristics of 
the patients and their spatial distribution. A second objective was to 
ascertain how many patients came from areas with reported elevated 
levels of uranium and uranium decay products. Acknowledging that 
a range of other factors such as referral patterns could play a major 
role in where the patients come from, this analysis was exploratory 
in nature. The outcomes would, however, assist in deciding whether 
a full-scale analytical study on uranium exposure and haematological 
cancer risk is feasible in this setting in terms of patient recruitment.
Methods
All cases of haematological malignancy diagnosed at CHBAH 
between the years 2004 and 2013 inclusive were included in this 
retrospective study based on routine clinical documentation. We 
extracted general demographic (sex and age at diagnosis) and clinical 
(precise cancer diagnosis, date of diagnosis and death, HIV status at 
diagnosis) information from the medical records of the Division of 
Clinical Haematology in the Department of Medicine at CHBAH, 
where all patients with a haematological malignancy are seen. The 
procedure was that all medical records of the Division from the 
period 2004 - 2013 were individually checked for any mention of a 
haematological malignancy (by AP) and eligibility to be included in 
the study database was confirmed by the lead haematologist (MP). 
Diagnosis was given as either a suspected or initial diagnosis (mostly 
without a specified disease subtype) as well as a final diagnosis, the 
latter generally with a disease subtype confirmed by a pathology 
report where available. We coded these diagnoses according to the 
International Classification of Diseases for Oncology, 3rd edition 
(ICD-O-3) and grouped them into five broad disease categories: 
Hodgkin’s lymphomas (HL), NHL, myeloma and related disorders 
(MM), leukaemia, and myelodysplastic/myeloproliferative neoplasms 
(MDS). Cases that had only a suspected/initial diagnosis, and cases 
with a final diagnosis but without detailed classification, were 
treated and coded as subgroups ‘not otherwise specified’. Cases with 
features of more than two subtypes within a broad disease group, 
such as ‘NHL unclassifiable between diffuse large B-cell lymphoma 
and Burkitt’s lymphoma’, were kept as they appeared in the original 
data. Cases with features of more than two subtypes across two 
broad disease groups, such as ‘Plasmablastic lymphoma and multiple 
myeloma’, were treated as unclear diagnoses and excluded from 
detailed analysis (but shown in the total number).
We also obtained the addresses of the patients from the medical 
records, supplemented by outpatient files, inpatient files, electronic 
hospital records and National Health Laboratory Service laboratory 
data. The local study team collected the address information from the 
widely distributed electronic health records system in SA called the 
Medicom system, by linking to the hospital file number, and converted 
it into co-ordinate data using a geographic information system (GIS) 
and Google Earth, a virtual geographic environment (VGE). We 
recoded the obtained co-ordinate data in GIS and identified sub-
place code, sub-place name, municipality code, municipality name, 
district code, district name, province, ward number and ward ID, 
which was possible most of the time even with uncertainties in exact 
GIS co-ordinates, as not all areas in and around Soweto use house 
numbers or even street names or those data were not recorded in 
detail. Sub-place refers to the smallest administrative boundary in 
SA, which is equivalent to a suburb, a village or a farm; ward is an 
electoral zone of a similar population size. We calculated the most 
direct distance from the patient residence to CHBAH (co-ordinates: 
–26.2597753, 27.9406257) using the haversine formula.
For the analyses, we mainly prepared frequency tables for clinical 
and for demographic variables. To calculate incidence rates, we used 
population denominators by administrative boundaries (provinces 
and wards) reported in the 2011 SA census. We combined haema-
tological malignancy cases for the entire study period (10 years) and 
obtained 10-year average annual incidence rates to avoid reporting 
too-strong random fluctuations caused by the small number of 
cases in each year. We further calculated truncated age-standardised 
incidence rates (for ages >20 years) using the Segi World standard 
population[11] for wards with >20 cases during the entire study period, 
for the same reason. Note that the calculated rates represented the 
incident cases from CHBAH in relation to population sizes of prov-
inces and wards, but are not to be confused with population-based 
incidence rates.
Ethical considerations
The study was approved by the IARC Ethics Committee (project no. 
14-19). Only the local study team had access to the raw and non-
anonymised data.
The data that support the study findings are available from 
the Division of Clinical Haematology, Department of Medicine, 
CHBAH, but restrictions apply to the availability of these data, 
which were used under licence for the current study and so are not 
publicly available. Data are, however, available from the authors upon 
reasonable request and with permission from CHBAH.
Results
General clinical characteristics of patients
Initially, 1 925 files were entered into the study database as potentially 
relevant to the study. These included 5 non-cancerous and 2 non-
haematological malignancy cases as well as 13 patients aged <18 years 
at diagnosis. Eleven patients were registered a second time during a 
repeat visit. All duplicate and irrelevant cases were excluded from the 
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study population, leaving 1 894 eligible cases. For 14 of these cases, 
the patient files were kept elsewhere within the hospital for academic 
purposes and detailed clinical information was not available to us 
by the end of the study period, leaving a total of 1 880 patients aged 
18 - 94 years for the study. For one case, sex was not recorded, and 
for 27 cases the age was unknown. HIV status was available for 42% 
of the total cases in 2004, but for >95% from 2006 on. In total, HIV 
status at diagnosis was known for 93% of the patients, of whom 47% 
were HIV-positive.
Race was not reported in any of the files, but CHBAH as a public 
hospital traditionally serves the black African population living in 
its large catchment area (confirmed by the head of the Division of 
Clinical Haematology, Prof. M Patel, 6 September 2017).
Table 1 shows the basic characteristics of the cases of haemato-
logical malignancy identified in the study. NHLs comprised 44% of 
the total, followed by leukaemia (26%) and MM (17%). Overall the 
sex ratio (M:F) was 1.03, but it differed by diagnosis, with NHL and 
MM affecting slightly more women, whereas HL, leukaemia and 
MDS were seen more often in men. Overall, 15% of patients were 
aged ≤30 years at diagnosis and 38% were aged ≥51 years, but age 
distributions differed across diagnostic subtypes. In 2004 and 2005, 
the NHL subtype was known for only 30% of patients diagnosed 
with NHL (NHL subtype was not stated in the database for 2004 and 
2005 in 70% of the patients, although it was known for most of the 
patients). This improved to 84 - 90% from 2008 onwards. Throughout 
the study period, the majority of NHL patients had diffuse large 
B-cell lymphoma (DLBCL). Burkitt’s lymphoma/leukaemia (BL) 
and plasmablastic lymphoma (PBL) were also common in this study 
population. Patients with these three NHL subtypes or with primary 
effusion lymphoma (PEL) were predominantly HIV-positive (81 - 
100%), confirming these subtypes to be HIV-associated, as previously 
reported.[12-15] More women with HIV-associated lymphomas had 
DLBCL or BL, while PEL and PBL were more often seen among men. 
HIV prevalence was generally low among patients with leukaemia, 
as well as among those with cancer types that affect older age groups 
such as MM and MDS.
Geographical distribution of patients
For each year, up to 60% of the registered addresses were found to 
be either incomplete or inaccurate, because local street names are 
often incorrectly recorded in the database or are not recognisable in 
the GIS system (and sometimes do not even exist, e.g. in informal 
settlements). The study population also included a number of 
patients (n=27) whose current residence or duration of stay in the 
reported residence was unknown. For these patients, only the address 
of a temporary residence was available, such as a referral hospital, 
Table 1. Basic characteristics of 1 880 patients diagnosed with a haematological malignancy at Chris Hani Baragwanath Academic 
Hospital, Johannesburg, South Africa, between 2004 and 2013
Cumulative 
total, n (%)
Age group (years), % Sex ratio 
(M/F)
HIV
18 - 30 31 - 4 0 41 - 50 ≥51 With data, n (%) Positive, n (%)
NHL 822 (44) 16 35 27 22 0.96 782 (95) 621 (76)
Myeloma and related disorders 325 (17) 0 6 23 71 0.92 291 (90) 26 (9)
HL 188 (10) 27 41 21 11 1.24 174 (93) 120 (69)
Leukaemias 487 (26) 20 13 18 50 1.11 453 (93) 54 (12)
MDS/MPN 45 (2) 2 11 7 80 1.25 45 (100) 3 (7)
Total (including 13 cases with 
unclear diagnosis)
1 880 (100) 15 24 23 38 1.03 1 757 (93) 830 (47)
NHL subtypes
B-cell
DLBCL 275 (34) 12 35 31 22 0.82 268 (97) 218 (81)
BL 127 (16) 28 42 21 10 0.81 124 (98) 120 (97)
PBL 115 (14) 14 43 34 10 1.59 113 (98) 110 (97)
DLBCL/BL 39 (5) 13 50 18 18 0.86 39 (100) 38 (97)
FL 15 (2) 0 13 27 60 1.14 15 (100) 0
PEL 8 (1) 25 50 13 13 1.67 7 (88) 7 (100)
MCL 7 (1) 0 0 0 100 2.50 7 (100) 0
MALT 7 (1) 14 0 43 43 2.50 7 (100) 3 (43)
DLBCL/PBL 5 (1) 0 40 40 20 1.50 5 (100) 5 (100)
T-cell
ALCL 18 (2) 28 28 28 17 0.80 15 (83) 7 (47)
PTCL 8 (1) 13 13 13 63 0.14 7 (88) 2 (29)
Mycosis fungoides 6 (1) 0 17 17 67 1.00 6 (100) 0
NHL, other subtypes 16 (2) 19 13 13 56 0.78 16 (100) 1 (7)
NHL, not otherwise specified 176 (21) 16 31 28 24 1.02 153 (87) 110 (72)
Leukaemia subtypes
Acute myeloid 204 (42) 25 16 20 40 1.00 196 (96) 28 (14)
Chronic lymphocytic 135 (28) 1 2 11 87 1.21 121 (90) 6 (5)
Chronic myeloid 112 (23) 18 20 25 37 1.00 102 (91) 16 (16)
Acute lymphocytic 36 (7) 64 17 14 6 2.00 34 (94) 4 (12)
NHL = Non-Hodgkin’s lymphoma; HL = Hodgkin’s lymphoma; MDS/MPN = myelodysplastic/myeloproliferative neoplasms; DLBCL = diffuse large B-cell lymphoma; BL = Burkitt’s lymphoma/
leukaemia; PBL = plasmablastic lymphoma; FL = follicular lymphoma; PEL = primary effusion lymphoma; MCL = mantle cell lymphoma; MALT = mucosa-associated lymphoid tissue 
lymphoma; ALCL = anaplastic large-cell lymphoma; PTCL = peripheral T-cell lymphoma.
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hostel, nursing home for the elderly or prison. In some cases, GIS 
co-ordinates were estimated by a given post office box number, the 
name of a nearby train station or the centre point of an administrative 
region, instead of an actual complete address. The address was 
missing for 0.9 - 13.1% of the total cases reported each year. However, 
we were still able to locate the address for 1 762 cases for assignment 
to the smallest administrative unit. Four cases with a foreign address 
were excluded (three from neighbouring countries within Africa and 
one from Oceania). Among the remaining 122 cases with address 
unknown, 14 had an invalid patient identifier number and one had an 
incomplete address, but the majority had no address at all registered 
in any of the available databases.
Among 1 758 patients with an SA address available, 90.5% 
came from Gauteng Province and 8.7% from North West Province 
(Table  2). Referral from distant provinces does occur, but >85% of 
the patients came from within 50 km of the hospital (Table 3), most 
originating from Soweto, where the hospital is located.
Table 3 shows the crude incidence rate (CIR, cases per 100 000 
residents per year) and the age-adjusted incidence rate (ASR) by 
province and their major geographical units (main place). The 
mean distance from the patients living in Soweto to the hospital was 
6.9 km. In addition, 154 patients lived in the surrounding areas of 
Johannesburg, while 181 came from a few larger townships nearby: 
87 from Orange Farm, 53 from Sebokeng and 41 from Katlehong. 
With a total of 46, the highest number of patients from North West 
came from a single referral hospital in Klerksdorp, 148.3 km from 
CHBAH.
Of the wards, 303 had at least one haematological malignancy 
patient during the study period, among them 24 wards with >20 
patients over the 10 years. The incidence rates were highest in Ward 
64003010 of Klerksdorp (CIR 30.2, ASR 52.7), and lowest in Ward 
79800053 of Dobsonville Gardens (CIR 3.8, ASR 6.9). Table 4 shows 
the 21 wards that had a minimum of 20 patients during the study 
period and an ASR >10.0 per 100 000 per year, which is roughly 
double the ASR for the whole of SA according to SA NCR data.[10] 
HIV prevalence among patients from these wards was generally 
high. According to the census of 2011, the proportion of dwellings 
in informal settlements in these wards (as a percentage of the total 
number of dwellings) ranged from 2.1% to 34.5%. Black Africans 
comprised the overwhelming majority of the population (99 - 100%) 
in 19 of the 21 wards, except for Lenasia which is known to be an 
Indian community, and Eldorado Park, predominantly inhabited by 
coloured (mixed race) people.
Fig. 1 shows the spatial distribution of wards with elevated cancer 
rates (with yellow to red shading indicating increasing cancer rates) 
in relation to lease areas (white boundary lines) and tailings deposits 
(bright red shading) of surrounding goldmines. The majority of 
areas with moderately high incidence rates were found in Soweto, 
close to CHBAH and within its catchment area. High incidence rates 
outside Soweto (Eldorado Park and Lenasia) were within a similar 
distance from CHBAH as some western parts of Soweto. The few 
sporadic wards with high incidence rates not in close proximity to 
CHBAH were Klerksdorp (outside the map in Fig. 1, also located in 
a goldmining area), Orange Farm and Ennerdale.
Discussion
Our retrospective case series found that a large number of patients 
can be recruited through CHBAH: each year during the 10-year study 
period, between 118 and 225 cases of haematological malignancy 
were seen at CHBAH. This corresponds to 4.7 - 7.1% of total cases of 
haematological malignancy and 9.7 - 12.3% of those in black Africans 
reported to the NCR between 2004 and 2011.[10]
The haematological malignancy patients at CHBAH came from 
a much larger catchment area than has previously been expected. 
This included neighbouring towns mostly within a 40 km radius 
of CHBAH, including the southern parts of Johannesburg, that 
are in fact closer to other tertiary or quaternary public hospitals 
such as Charlotte Maxeke Johannesburg Academic Hospital and 
Helen Joseph Hospital. Apart from Soweto, which straddles the 
Central Rand and West Rand goldfields, a relatively large number of 
patients also came from nearby townships with limited local medical 
Table 2. Geographical distribution of patients (registered 
address at diagnosis): distance to the hospital (N=1 758)
Distance (km) Patients, n (%)
<1 766 (43.5)
10 - 19 347 (19.7)
20 - 29 229 (13.0)
30 - 39 112 (6.4)
40 - 49 74 (4.2)
≥50 234 (13.3)
Table 3. Geographical distribution of patients (registered address at diagnosis): incidence by registered address at diagnosis (N=1 758)*
Province/main place Mean distance (km) n (% of total) Population CIR ASR Population (equivalent wards)
Gauteng 16.0 1 591 (90.5) 12 272 263 1.3 2.2 12 272 263
Soweto 6.9 814 (46.3) 1 271 628 6.4 10.7 1 321 333
Johannesburg 7.7 154 (8.8) 957 441 1.6 3.2 857 207
Orange Farm 24.5 87 (4.9) 76 767 11.3 13.6 118 682
Lenasia 12.4 58 (3.3) 89 714 6.5 6.7 156 140
Sebokeng 35.1 53 (3.0) 218 515 2.4 5.6 152 163
Katlehong 24.0 40 (2.3) 407 294 1.0 2.6 311 581
North West 182.7 153 (8.7) 3 509 953 0.4 0.8 3 509 953
Klerksdorp 148.3 46 (2.6) 186 515 2.5 6.7 107 480
Mpumalanga 204.2 7 (0.4) - - - -
Free State 65.7 3 (0.2) - - - -
Eastern Cape 713.1 2 (0.1) - - - -
KwaZulu-Natal 478.3 1 (0.1) - - - -
Western Cape 1 165.9 1 (0.1) - - - -
CIR = crude incidence rate (cases per 100 000 residents per year); ASR = age-adjusted incidence rate.
*‘Population’, ‘CIR’, ‘ASR’ and ‘Population (equivalent wards)’ were not calculated for Mpumalanga, Free State, Eastern Cape, KwaZulu-Natal and Western Cape owing to the very low numbers 
(<10 cases).
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facilities, such as Orange Farm, Sebokeng 
and Katlehong, as well as from the Indian 
settlement of Lenasia. Overall, the catchment 
area in this study resembled that for breast 
cancer patients at CHBAH,[16] except that 
some haematological malignancy patients 
came from even more far-flung areas of up to 
150 km away (i.e. the Klerksdorp goldfield).
The clinical information obtained in this 
study was relatively complete, and ~40% 
of the cases were confirmed by pathology 
reports. Given the largely unknown cancer 
patterns in sub-Saharan Africa, the data 
presented are of importance in understanding 
the haematological malignancy burden of 
the area. In accordance with the results 
of another study in a similar geographical 
setting (the broader metropolitan 
municipality of Johannesburg) between 2004 
and 2009,[12] DLBCL was the leading NHL 
subtype over the entire study period.
The prevalence of HIV infection in our 
study population was ~2.5 - 4 times higher 
than the national level of 10.2% (all ages) 
or 16.8% (15 - 49-year-olds),[17] and more or 
less the same as in the abovementioned study 
(44.3 - 62.0%),[12] suggesting that it is the 
typical prevalence for adult haematological 
malignancy patients. Infections play 
an important role in the aetiology of 
haematological malignancies. For example, 
Epstein-Barr virus infection is related to 
risk of BL, HL, nasal natural killer T-cell 
lymphoma and other B-cell NHLs.[18] HIV 
infection increases the risk of developing 
NHL, HL and leukaemia. Previous studies 
have shown some NHL subtypes, such as 
DLBCL, BL and PBL, to be associated with 
HIV.[12-15] This has implications for any future 
studies, as infections need to be accounted 
for when investigating environmental risk 
factors, and information on HIV status in 
particular needs to be collected. Our active 
case collection from clinical records revealed 
much more detailed clinical information 
than would have been obtainable through 
the NCR data. Information on detailed NHL 
subtypes is important in understanding 
the potential impact of infections on the 
observed burden.
The categorisation of haematological 
malig nancies in broad disease groups 
showed NHL to be the most common in this 
study population, followed by leukaemia. 
This pattern corresponds to that of NCR 
data,[10,19] as well as figures for sub-Saharan 
Africa in general.[18] In black Americans in 
the USA and black African ethnic groups 
in the UK, on the other hand, exceptionally 
high incidence rates of myeloma and related 
disorders render this disease group the 
second most common following NHL.[20,21] 
However, if each of the four subtypes of 
leukaemia is regarded as a separate entity, 
multiple myeloma as a single disease entity 
is the second most common haematological 
malignancy after NHL. The different disease 
profile seen in the high-income countries 
would mainly be explained by demographic 
factors such as life expectancy and age 
structure of the countries, and also the HIV 
burden.
Study limitations
The spatial distribution of incidence rates 
indicates the presence of geographical 
clusters. However, in our study this needs 
very careful interpretation, as with a hospital-
based case collection clusters may have 
formed as a result of referral patterns rather 
than the true disease burden in the area. For 
example, of the 21 patients from the ward 
in Klerksdorp with the highest ASR in this 
study, 20 originated from exactly the same 
geographical co-ordinates, reflecting the 
location of the referring hospital rather than 
the patients’ residential addresses. Similarly, 
the third-largest number of patients came 
from Orlando East in Soweto, where 21 out 
of 37 patients were registered at the address 
of a specific hospice. Clusters at addresses 
of district hospitals or general practitioners 
were also observed for Chiawelo, Jabulani 
and Dobsonville. This illustrates the practi-
cal difficulties arising from the frequent lack 
of street addresses and house numbers in 
many townships.
In addition to such referral patterns, 
several other factors such as the poor 
population registration of the area, migra-
tion of residents and individual choice of 
hospital were found to preclude any future 
study from population-based recruitment 
via the CHBAH route alone. A specific 
sub-place (Extension 8) in Orange Farm 
had the largest number of patients, but the 
co-ordinates of their addresses showed that 
77 out of 78 patients from Orange Farm used 
a post box number as their address. Some 
areas including Orange Farm are particularly 
impoverished and have large informal 
settlements, so that accurate residential 
co-ordinates cannot be established from 
hospital records alone. In addition, there 
are substantial differences between the 
census population and the actual number 
of people living in the areas, introducing 
further uncertainty in the estimation of 
any rates. In some other cases, exactly the 
same address (school, religious institution, 
train station, police station, park, etc.) was 
used for several patients. In any future 
epidemiological studies, patients would 
have to be interviewed about their true 
resi dential history, as neither the hospital 
records nor the NCR has sufficiently reliable 
and detailed information. This is important 
for investigating the possible relationship 
between uranium exposure and cancer, as 
patients may have moved away from the 
address they lived at during the relevant 
exposure time window, which may range 
from several years before diagnosis up to 
decades before diagnosis.
Another limitation of the retrospective 
collection of clinical data in this study was 
that data on patient ethnicity were not 
available, although 95% of patients were 
assumed to be black. Ethnic composition 
of the study population is directly related to 
different incidence patterns as well as patient 
choice of hospital. Previous studies have 
Fig. 1. Google Earth satellite image of the study area indicating the location of goldmines (lease areas, 
white boundary lines), uraniferous tailings deposits (red) and a superimposed map of wards with 
elevated rates of haematological malignancies (calculated based on total population, with yellow to red 
shading indicating increasing rates of haematological malignancies).
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revealed that white patients mostly go to private hospitals.[16,19] Any 
calculation of incidence rates needs to be specific according to ethnic 
group, if data are available.[18] For ascertainment of cases in children 
and adolescents, the respective paediatric oncology clinics would 
need to be included.
Another limitation is that mere distance to goldmines is a rela-
tively poor predictor of uranium exposure, since factors such as 
uranium levels in tailings, the status of tailings deposits (vegetated 
or not, active or decommissioned), prevailing wind directions and 
resulting dust plumes, and existence and course of polluted streams 
are all crucial for determining the extent of possible exposure of 
adjacent residents. In future studies it will therefore be essential to 
analyse the areas of interest in terms of exposure patterns rather than 
simply distance to mining sites. Results extracted from >60 previous 
measurement surveys georeferenced and collated in a combination 
of GIS and VGE provide levels of uranium (and other radioactive 
isotopes such as radium 226) in water, soil, air and biota (including 
foodstuff) that can be used for detailed mapping of exposure 
pathways and patterns.[22] Furthermore, occupational exposure to 
uranium of patients who worked or are still working at the goldmines 
also needs to be captured.
Conclusions
With regard to the feasibility of any future epidemiological studies 
on haematological malignancies, our data show that case ascertain-
ment through CHBAC would provide good coverage of the true 
disease burden of the majority of the local black population and 
allow for recruitment of large numbers of cases. However, the data 
also show that active recruitment is necessary to obtain accurate 
residential information, including on residential mobility, which 
is not sufficiently well covered by the hospital records or in the 
cancer registry. Furthermore, information on possible occupational 
exposure and dietary habits as well as sources of drinking water, food, 
etc. are required. Data on HIV, on the other hand, also essential for 
any interpretation of disease clustering, are sufficiently complete in 
the hospital records.
Our study also shows that retrospective case collections cannot 
be used to link observed disease patterns to environmental uranium 
exposure, as the clinical records do not provide sufficiently good 
address data and do not reflect population-based incidence rates 
owing to patterns of referral to the hospital. However, some of 
the areas observed to have an elevated incidence may not be fully 
explained by factors such as referral patterns or poor population 
registration. Acknowledging all the above limitations, we found that 
high incidence rates were all observed in proximity to historical or 
currently operating goldmines. As they were also in close proximity to 
CHBAH, these two factors cannot be disentangled on the basis of our 
data alone. Nevertheless, this finding suggests that further research 
on environmental contamination and the risk of haematological 
malignancies in this area is warranted.
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